Kestra Medical Technologies, Ltd. (KMTS) stock

KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 5/30

$28.64+0.02 (+0.07%)

Close on Nov 13, 2026Market cap $1.71BP/E –Yield –

Kestra Medical Technologies enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Kestra Medical Technologies's enterprise value was $1.70B on Nov 11, 2026, against $1.23B a year earlier.

Period	Period end	Value	Change
2026	Nov 11, 2026	$1.70B	+38.3%
2025	Dec 31, 2025	$1.23B	–

Parsed from the XBRL in Kestra Medical Technologies's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is KMTS.

Revenue growth60.7% · median 11.0%

Gross margin53.9% · median 75.5%

Operating margin-134.5% · median -72.7%

Net margin-140.4% · median -65.3%

Advertisement
300 × 250

See a number that looks wrong?